REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options / PDMR dealing

14 May 2021 10:11

RNS Number : 6827Y
Sopheon PLC
14 May 2021
 

For Immediate Release

 

 

 

 

SOPHEON PLC

("Sopheon" or "the Company")

 

Grant of Options / PDMR dealing

 

Sopheon announces that the Company has granted options over ordinary shares of 20 pence each in the share capital of the Company ("Options") to three executive directors.

 

Gregory Coticchia, the recently appointed CEO has been granted 80,000 Options at an exercise price of 845p, being the mid-market closing price on AIM on 13 May 2021, the last business day prior to the grant. Including this grant, the total number of Options held by him is 100,000.

 

Andrew Michuda, Executive Chairman and Arif Karimjee, CFO have been granted 165,000 and 43,350 Options respectively at an exercise price of 900p. Including this grant, the total number of Options held by each is 320,000 and 93,000 respectively.

 

The Options granted will vest over 3 years and are exercisable up to 10 years from the date of grant. Including the grant of these options, the Company will have outstanding options over approximately 9.5% of its issued share capital.

 

Notice of AGM

 

The Company also confirms it is posting its Notice of AGM ("Notice") to shareholders today, and will also publish the Notice on the Company's website. The AGM will be held on 10 June 2021.

 

For further information contact:

Andy Michuda, Executive ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (corporate finance)

Alice Lane (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 250 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Gregory Coticchia

2.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 845 pence per share

80,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 80,000 options over ordinary shares of 20p pence at an exercise price of 845 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

2.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Arif Karimjee

3.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

4.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

5.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price 900 pence per share

43,350

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 43,350 options over ordinary shares of 20p pence at an exercise price of 900 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Michuda

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

 

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 20p

 

 

Identification code

GB00BSZM1369

b)

Nature of the transaction

 

Grant of Options

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise Price 900 pence per share

165,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

Grant of 165,000 options over ordinary shares of 20p pence at an exercise price of 900 pence

e)

Date of the transaction

14 May 2021

f)

Place of the transaction

Outside of trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKQBKCBKKAPD
Date   Source Headline
10th Jun 20217:00 amRNSAGM Statement
3rd Jun 20211:50 pmRNSIssue of Equity
2nd Jun 20217:00 amRNSSopheon Deployed Globally at The 3M Company
14th May 202110:11 amRNSGrant of Options / PDMR dealing
14th Apr 20217:00 amRNSLaunch of Accolade for Smart Products
9th Apr 20214:15 pmRNSIssue of Equity
31st Mar 20217:00 amRNSDirectorate Change
29th Mar 20212:30 pmRNSDirector Shareholdings
24th Mar 20217:00 amRNSFinal Results
3rd Mar 202111:02 amRNSHolding(s) in Company
2nd Mar 202112:12 pmRNSHolding(s) in Company
26th Feb 20214:20 pmRNSResult of Secondary Placing
26th Feb 20211:36 pmRNSProposed Secondary Placing
8th Feb 20214:30 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSSopheon extend innovation leadership with Simplot
25th Jan 20217:00 amRNSTrading Update
5th Nov 20207:00 amRNSRelease of Accolade version 13.2
12th Oct 20207:00 amRNSSeasoned Cloud & Industry Executive added to Team
9th Sep 20209:55 amRNSOrion Engineered Carbons works with Sopheon
1st Sep 202011:38 amRNSDirector Shareholdings
28th Aug 202012:39 pmRNSIssue of Equity
27th Aug 20207:00 amRNSInterim Results
30th Jul 20207:00 amRNSMondelez Partnership
13th Jul 202011:41 amRNSGrant of Options/PDMR Dealing
11th Jun 202011:28 amRNSResult of AGM
9th Jun 202012:00 pmRNSIssue of Equity & Director/PDMR Shareholding
28th May 20207:29 amRNSProgressive publishes new research
28th May 20207:00 amRNSNew Sopheon Release Integrating Microsoft Teams
15th May 202010:01 amRNSIssue of Equity
15th May 20207:00 amRNSAGM Notice and Update
3rd Apr 202011:17 amRNSDirector Shareholdings
25th Mar 20201:38 pmRNSIssue of Equity
19th Mar 20204:46 pmRNSIssue of Equity
19th Mar 20207:00 amRNSFinal Results
28th Jan 20209:05 amRNSSecond Price Monitoring Extn
28th Jan 20209:00 amRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSTrading Update
10th Jan 20201:00 pmRNSIssue of Equity
11th Dec 20197:00 amRNSTrading Update
10th Oct 201912:00 pmRNSIssue of Equity
1st Oct 201912:00 pmRNSIssue of Equity
20th Sep 20194:45 pmRNSIssue of Equity
22nd Aug 20192:06 pmRNSSecond Price Monitoring Extn
22nd Aug 20192:01 pmRNSPrice Monitoring Extension
22nd Aug 201911:05 amRNSSecond Price Monitoring Extn
22nd Aug 201911:00 amRNSPrice Monitoring Extension
22nd Aug 20199:05 amRNSSecond Price Monitoring Extn
22nd Aug 20199:00 amRNSPrice Monitoring Extension
22nd Aug 20197:00 amRNSHalf-year Report
12th Aug 201910:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.